Intensity Therapeutics, Inc. Common stock (INTS) Dividend History

Intensity Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for solid tumors. The company aims to harness the body’s immune response to target and destroy cancer cells through its proprietary immunotherapy platforms. Based in the United States, Intensity Therapeutics is involved in research and development efforts to advance novel therapies for cancer patients.